docs/_posts/Ahmetemintek/2022-11-16-abbreviation_category_mapper_en.md
docs/_posts/Ahmetemintek/2022-11-18-kegg_disease_mapper_en.md
docs/_posts/Ahmetemintek/2022-11-21-kegg_drug_mapper_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_anatomy_general_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_anatomy_granular_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_biomarker_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_demographics_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_diagnosis_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_posology_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_response_to_treatment_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_test_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_therapy_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_tnm_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_unspecific_posology_en.md
docs/_posts/Cabir40/2022-11-22-ner_clinical_bert_ro.md
docs/_posts/Cabir40/2022-11-22-ner_deid_generic_bert_ro.md
docs/_posts/Cabir40/2022-11-22-ner_living_species_300_es.md
docs/_posts/mauro-nievoff/2022-12-01-oncology_biomarker_pipeline_en.md
docs/_posts/mauro-nievoff/2022-12-01-oncology_diagnosis_pipeline_en.md
docs/_posts/mauro-nievoff/2022-12-01-oncology_general_pipeline_en.md
docs/_posts/mauro-nievoff/2022-12-01-oncology_therapy_pipeline_en.md
docs/_posts/Ahmetemintek/2022-11-16-abbreviation_category_mapper_en.md
docs/_posts/Ahmetemintek/2022-11-18-kegg_disease_mapper_en.md
docs/_posts/Ahmetemintek/2022-11-21-kegg_drug_mapper_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_anatomy_general_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_anatomy_granular_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_biomarker_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_demographics_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_diagnosis_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_posology_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_response_to_treatment_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_test_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_therapy_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_tnm_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_unspecific_posology_en.md
docs/_posts/Cabir40/2022-11-22-ner_clinical_bert_ro.md
docs/_posts/Cabir40/2022-11-22-ner_deid_generic_bert_ro.md
docs/_posts/Cabir40/2022-11-22-ner_living_species_300_es.md
docs/_posts/mauro-nievoff/2022-12-01-oncology_biomarker_pipeline_en.md
docs/_posts/mauro-nievoff/2022-12-01-oncology_diagnosis_pipeline_en.md
docs/_posts/mauro-nievoff/2022-12-01-oncology_general_pipeline_en.md
docs/_posts/mauro-nievoff/2022-12-01-oncology_therapy_pipeline_en.md
